SRTA SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 43,577,059 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50

Jun 13, 2022

424B3

UPDATED | OFFERING | Shares amount: 56,345,774 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50

May 19, 2022

424B3

UPDATED | OFFERING | Shares amount: 56,345,774 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50

May 10, 2022

424B3

UPDATED

Mar 22, 2022

424B3

UPDATED | OFFERING | Shares amount: 56,345,774 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50

Mar 17, 2022

424B3

UPDATED | OFFERING | Shares amount: 56,345,774 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50

Jan 28, 2022

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 21, 2025

S-8

Registration

Feb 23, 2024

POS AM

Up to 43,777,059 Shares of Class A common stock EFFECTIVE

Jun 2, 2022

POS AM

Up to 56,345,774 Shares of Class A common stock EFFECTIVE

Jan 21, 2022

S-8

Registration

Jul 15, 2021

S-1

SHARE RESALE REGISTRATION | Shares amount: 61,447,890 | Share price: $8.64 | Warrants amount: 5,000,000 | Warrants exercise price: $11.50 EFFECTIVE

May 28, 2021

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 14, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 14, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 24, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 24, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 22, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 22, 2024

Ownerships

TYPE

HEADLINE

FILED AT

NEWLAUCK ANDREW (Reporting)

Nov 9, 2026

Wunsch Scott M (Reporting)

Oct 30, 2026

SCHEDULE 13D

Third Point LLC (Filed by)

Oct 15, 2026

144

Form 144 - Report of proposed sale of securities

Oct 2, 2026

Tomkiel Melissa M. (Reporting)

Sep 25, 2026

Heyburn William A. (Reporting)

Sep 25, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 13, 2022

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 28, 2022

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 8, 2021

CORRESP

Form CORRESP - Correspondence

Jun 3, 2021

LETTER

Form UPLOAD - SEC-generated letter

Jun 2, 2021

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 7, 2021

Strata Critical Medical, Inc. SRTA · SEC Filings